PRESS RELEASE published on 05/06/2024 at 23:25, 1 year 9 months ago Jolt Health To Acquire HCQ Transdermal Patch Technology Jolt Health Inc. acquires intellectual property for transdermal delivery tech of HCQ & CQ to address underserved lupus, rheumatoid arthritis, and malaria markets worth $6B by 2027* Jolt Health Inc. Hydroxychloroquine Transdermal Delivery Technology Chloroquine FDA Approved
BRIEF published on 03/27/2024 at 21:55, 1 year 10 months ago Jolt Health Inc. annonce la clôture du financement Financement Placement Privé Remboursement De Dette Jolt Santé Inc. Fonds De Roulement
BRIEF published on 03/27/2024 at 21:55, 1 year 10 months ago Jolt Health Inc. Announces Closing of Financing Private Placement Working Capital Financing Debt Repayment Jolt Health Inc
PRESS RELEASE published on 03/27/2024 at 21:50, 1 year 10 months ago Jolt Health Inc. Announces Closing of Financing Jolt Health Inc. closes non-brokered private placement of 50,000,000 units at $0.01 per unit for gross proceeds of $500,000. Proceeds to be used for working capital and debt repayment. Insider participation and warrant details disclosed Private Placement Working Capital Non-brokered Common Share Jolt Health Inc.
BRIEF published on 03/08/2024 at 13:05, 1 year 10 months ago Jolt Health Inc. annonce des expansions stratégiques et des changements au conseil d'administration Santé Et Bien-être Médicaments Jolt Santé Inc. Développement De Médicaments IA Financement Par Placement Privé
BRIEF published on 03/08/2024 at 13:05, 1 year 10 months ago Jolt Health Inc. Announces Strategic Expansions and Board Changes Pharmaceuticals Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development
PRESS RELEASE published on 03/08/2024 at 13:00, 1 year 10 months ago Jolt Health Inc., Letter to the Shareholders Jolt Health Inc. focuses on health & wellness, AI drug dev., pharma sectors. Company adds Mr. Cody Corrubia to the board & announces private placement financing. Read the letter to shareholders for details Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development Pharmaceutical Sectors
PRESS RELEASE published on 02/27/2023 at 23:10, 2 years 11 months ago Love Pharma Inc. Announces Share Consolidation
Published on 02/07/2026 at 01:00, 15 hours 7 minutes ago Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 16 hours 57 minutes ago Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 18 hours 6 minutes ago Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 2 hours ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 19:25, 20 hours 41 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 22 hours 14 minutes ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 22 hours 27 minutes ago Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 23 hours 11 minutes ago GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 1 day ago CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner
Published on 02/06/2026 at 18:22, 21 hours 44 minutes ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 21 hours 44 minutes ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 1 day ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 1 day 8 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
